A box of Ozempic made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams/Reuters
President Donald Trump announced on May 1 that Medicare patients will soon be able to obtain coverage for weight-loss drugs for $50 per month.
Speaking at an event in Florida, Trump said the coverage for the weight-loss and diabetes medications will begin in July, referencing drugs that contain semaglutide, a GLP-1 receptor agonist.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.